Presented at AACR 2024: Expanding the reach of T-cell engagers
Scientific Case Studies
Presentations & Posters
Presented at SITC 2023: Streamlining T-cell engager development
Presented at AACR 2023: AbCellera’s T-cell engager platform
Presented at SITC 2022: CD3 T-cell engagers that strike the right balance
Presented at AACR 2022: CD3-binding antibodies for T-cell engager discovery
Publications
Developability considerations for bispecific and multispecific antibodies
Potent transmission-blocking monoclonal antibodies from naturally exposed individuals target a conserved epitope on Plasmodium falciparum Pfs230
Highly potent, naturally acquired human monoclonal antibodies against Pfs48/45 block Plasmodium falciparum transmission to mosquitoes